Repeat spine SBRT is a feasible salvage option for local recurrence after prior SBRT. In this retrospective series of 49 patients and 115 spine segments that were retreated with SBRT, local failure was 25% at 12 months. Median dose was 30 Gy in 5 fractions. No patients developed myelopathy, and the rate of vertebral compression fractures was 12%. A minimum target volume dose of 28 Gy EQD2 (a/B=10) was associated with a lower risk of local failure. | Messing, Adv Radiat Oncol 2026

